{"id":"NCT02384941","sponsor":"Lexicon Pharmaceuticals","briefTitle":"Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy","officialTitle":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of LX4211 as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2016-09","completion":"2017-02","firstPosted":"2015-03-10","resultsPosted":"2019-11-25","lastUpdate":"2020-02-12"},"enrollment":793,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Sotagliflozin","otherNames":["LX4211"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Sotagliflozin 200 milligrams (mg)","type":"EXPERIMENTAL"},{"label":"Sotagliflozin 400 mg","type":"EXPERIMENTAL"}],"summary":"This Phase 3 study was intended to demonstrate superiority of either sotagliflozin high dose or low dose versus placebo on glycosylated hemoglobin A1C (A1C) reduction at Week 24 when used as an adjunct in adult participants with type 1 diabetes mellitus (T1D) who have inadequate glycemic control with insulin therapy.","primaryOutcome":{"measure":"Change From Baseline in A1C at Week 24","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.07,"sd":0.036},{"arm":"Sotagliflozin 200 mg","deltaMin":-0.43,"sd":0.036},{"arm":"Sotagliflozin 400 mg","deltaMin":-0.48,"sd":0.036}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":4},"locations":{"siteCount":75,"countries":["United States","Canada"]},"refs":{"pmids":["32928957","32721228","31587812","30833371","29937430"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":268},"commonTop":["Upper respiratory tract infection","Viral upper respiratory tract infection","Diarrhoea","Nausea","Urinary tract infection"]}}